Two Federal Circuit decisions, three months apart, analyzed enablement of similarly broad method-of-treatment claims, but reached opposite outcomes. In April
Continue Reading The Evolving Law of Enablement: Federal Circuit Decisions in Wyeth and Teva Form a “Yin and Yang” Framework
For the past few months, the beneficial ownership reporting obligations under the Corporate Transparency Act (the “CTA”) have fluctuated between
Continue Reading Corporate Transparency Act Requirements Are Back: March 21, 2025 Deadline Looms
Only days after lifting the nationwide preliminary injunction, the Fifth Circuit Court of Appeals vacated their decision to stay the
Continue Reading Latest Update: Corporate Transparency Act Halted Again
As an update to our posts on the ongoing attempts to block the Corporate Transparency Act, on December 23, 2024
Continue Reading Update: Corporate Transparency Act Reinstated by Appeals Court: January 1 Deadline Looms
As an update to our post on the Corporate Transparency Act, on December 3, 2024, a federal district court issued
Continue Reading Update: The Corporate Transparency Act Put On Hold
The food tech industry has been growing and evolving rapidly in the last ten years due to technological innovations in
Continue Reading Meating of the Minds: Impossible Foods and Motif Foodworks Settle High Profile Patent Dispute in District Court
After decades of intense scientific research into developing gene editing technologies, and more than a few setbacks, the field has
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Treatments Offer New Hopes for Rare Diseases
In a cautionary tale for inventors participating in trade shows and other non-confidential presentations, on February 15, 2023, the U.S.
Continue Reading Patent Invalid Due to Trade Show Demonstration More Than One Year Before Filing Date
On April 13, 2022, the European Commission submitted a proposed regulation on the protection of Geographical Indications for Craft and
Continue Reading Geographical Indications in the EU: A Step Forward in the Protection of Traditional Artisanal Skills
In the first major patent infringement lawsuit in the mRNA space, on February 28, 2022, Arbutus Biopharma Corporation (“Arbutus”) and
Continue Reading Arbutus and Genevant Sue Moderna in First Significant Patent Infringement Lawsuit in the mRNA Space